复方益肝灵预防抗结核药物致肝损伤的疗效观察  被引量:12

Observation of the Curative Effect of Compound Liver-benepitino in the Prevention of Hepatic Lesion Caused by Antituberculotic

在线阅读下载全文

作  者:朱岩[1,2] 朱文丽[1] 

机构地区:[1]北京大学公共卫生学院,北京100191 [2]北京市朝阳区疾病预防控制中心,北京100026

出  处:《长春中医药大学学报》2013年第1期43-45,共3页Journal of Changchun University of Chinese Medicine

摘  要:目的:探讨复方益肝灵预防抗结核药物致肝损伤的临床疗效。方法:采用前瞻性研究,对384例门诊肺结核患者随机分为复方益肝灵治疗组192例和对照组192例,前者予复方益肝灵(主要成分为水飞蓟素和五味子提取物五仁醇浸膏)和抗结核药物联合治疗,后者进行常规抗结核治疗并加服葡醛内酯片,6~8个月为1疗程,疗程结束后比较2组的临床症状、体征和肝功能变化情况。结果:加用复方益肝灵后,治疗组肺结核患者发生药物性肝损伤41例,病情轻微,而对照组发生药物性肝损伤138例,发生率分别为21.4%和71.9%,2组比较具有统计学意义(P〈0.05)。2组抗结核治疗过程中治疗组有7例(3.6%)、对照组有21例(10.9%)中断抗结核治疗,2组比较有统计学意义(P〈0.05)。结论:复方益肝灵可有效预防抗结核药物所致的肝损伤,不良反应少且轻微。Objective: To assess the clinical efficacy of compound liver-benepitino remedy in preventing liver injurycaused by antituberculosis drugs. Methods:We divided 384 tuberculosis patients into treatment group and control group ran- domly. The former were treated with compound liver-benepitino remedy and antituberculosis drugs, and the later were treated with antitubereulosis drugs and glucurolactone tablets. The course of the treatment was from 6 months to 8 months, and after completing the treatment, compare the clinical symptoms, physical signs and the function of liver between two groups. Re- suits:In treatment group (192 cases), 41 patients had the slight liver injure, but in control group, 138 patients had the liver injure. The incidences were 21.4 % in treatment group and 71.9 % in control group respectively, and the difference was sta- tistically significant ( P 〈 0.05). In process of treatment, 7 (3.6 % ) patients' treatments were discontinued, and 21 ( 10.9 % ) patients' treatments were discontinued, the difference between two groups was statistically significant (P 〈 0.05). Conclu- sions:Compound liver-benepitino remedy can prevent the liver injure caused by antituberculosis drugs, there are less side ef- facts, anrl the side effects also were slight, so it have some clinical value.

关 键 词:肝损伤 抗结核药 预防 控制 复方益肝灵 

分 类 号:R256.4[医药卫生—中医内科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象